Moderna, Inc. (NASDAQ:MRNA) | WebDisclosure

Basculer en Français

9480	Companies
185523	Keywords
117909	Articles
99369	Press releases

Home
Companies
Moderna, Inc.

BRIEF

published on 10/13/2025 at 00:10, 1 month 23 days ago

Moderna annonce des résultats préliminaires encourageants pour son traitement contre le cancer

Thérapie Contre Le Cancer Moderne Congrès De L'ESMO ARNm-4359 Évasion Immunitaire
BRIEF

published on 10/13/2025 at 00:10, 1 month 23 days ago

Moderna Reports Encouraging Early Results for Cancer Therapy

Cancer Therapy Moderna ESMO Congress MRNA-4359 Immune Evasion
PRESS RELEASE

published on 10/13/2025 at 00:05, 1 month 23 days ago

Moderna Presents Promising Early Data for Its Investigational Cancer Antigen Therapy at the 2025 European Society for Medical Oncology Congress
Moderna's mRNA-4359 advances to Phase 2 in CPI-R/R melanoma patients. Promising data on tumor response rates and safety presented at ESMO Congress 2025

Moderna Phase 2 MRNA-4359 CPI-R/R Melanoma Tumor Response
BRIEF

published on 09/25/2025 at 01:06, 2 months 10 days ago

Moderna Launches New Manufacturing and R&D Facility in the UK

MRNA Vaccines NHS Moderna UK Facility Health Resilience Pandemic Readiness
BRIEF

published on 09/25/2025 at 01:06, 2 months 10 days ago

Moderna lance une nouvelle usine de fabrication et de recherche et développement au Royaume-Uni

Vaccins À ARNm Installation De Moderna Au Royaume-Uni Résilience En Matière De Santé Préparation À La Pandémie Service National De Santé (NHS)
PRESS RELEASE

published on 09/25/2025 at 01:01, 2 months 10 days ago

Moderna Opens State-of-the-Art Manufacturing and R&D Facility in the UK
Moderna's Innovation and Technology Centre in Oxfordshire is now operational, producing British-made mRNA vaccines for the UK population and advancing mRNA science in various areas

Innovation UK Moderna MRNA Vaccines Technology Centre
BRIEF

published on 09/23/2025 at 13:05, 2 months 12 days ago

Le vaccin mNEXSPIKE de Moderna démontre une forte réponse immunitaire contre le variant LP.8.1 de la COVID-19

Moderne Vaccin Contre Le Covid-19 Réponse Immunitaire Variante LP.8.1 MNEXSPIKE
BRIEF

published on 09/23/2025 at 13:05, 2 months 12 days ago

Moderna's mNEXSPIKE Shows Strong Immune Response Against COVID-19 LP.8.1 Variant

COVID-19 Vaccine Moderna Immune Response LP.8.1 Variant MNEXSPIKE
PRESS RELEASE

published on 09/23/2025 at 13:00, 2 months 12 days ago

Moderna Announces mNEXSPIKE Generates Strong Immune Response Against LP.8.1 Variant in Humans
Moderna's 2025-2026 mNEXSPIKE formula shows significant increase in LP.8.1-neutralizing antibodies, demonstrating strong immune responses against COVID-19 strains. Preliminary immunogenicity data supports the efficacy and safety of the vaccine

COVID-19 Vaccine Moderna MNEXSPIKE Immunogenicity Data LP.8.1-neutralizing Antibodies
BRIEF

published on 09/19/2025 at 21:40, 2 months 15 days ago

Moderna livre les premiers vaccins ARNm fabriqués au Canada

COVID-19 Canada Moderna Production Locale Vaccins ARNm

Accesswire

Published on 12/05/2025 at 18:20, 4 minutes ago

NuRAN Announces Intention to Complete Consolidation in Preparation to the Restructuring Transaction
Published on 12/05/2025 at 18:00, 24 minutes ago

SMX: A New Supply Chain Reality in the World's Four Largest Markets
Published on 12/05/2025 at 17:15, 1 hour 9 minutes ago

TRX GOLD Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 17:00, 1 hour 24 minutes ago

Three Trillion-Dollar Frontiers, One Technology: How SMX Is Everywhere at Once
Published on 12/05/2025 at 16:00, 2 hours 24 minutes ago

SMX Didn't Change Its Story; The World Finally Connected the Dots

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 18:15, 9 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:51, 33 minutes ago

Issue of Equity
Published on 12/05/2025 at 17:46, 38 minutes ago

Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds
Published on 12/05/2025 at 17:00, 1 hour 24 minutes ago

EQS-Adhoc: The NAGA Group AG adjusts guidance for financial year 2025 following continued low volatility and weaker year-end performance
Published on 12/05/2025 at 16:25, 1 hour 59 minutes ago

4YFN26 Awards: Meet the Top 20 startups building the future

Les Echos

Published on 12/05/2025 at 17:18, 1 hour 6 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 1 hour 6 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 3 hours 14 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 3 hours 14 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 4 hours 26 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE

View all LES ECHOS COMFI WIRE